National survey of Canadian Retina Society members on guidelines for ophthalmic care during the COVID-19 crisis: Canadian Retina Research Network (CR2N) COVID-19 Steering Committee analysis

Varun Chaudhary; Daniel Rosenberg; Joshua Barbosa; Cynthia Qian; Alan Berger; James Whelan; Amin Kherani; Arif Samad; Jason Noble

doi:10.1016/j.jcjo.2020.06.001

National survey of Canadian Retina Society members on guidelines for ophthalmic care during the COVID-19 crisis: Canadian Retina Research Network (CR2N) COVID-19 Steering Committee analysis

Varun Chaudhary, Daniel Rosenberg, Joshua Barbosa, Cynthia Qian, Alan Berger, James Whelan, Amin Kherani, Arif Samad, Jason Noble

Medicine

Medicine

Résultat de recherche: Letter › examen par les pairs

3 Citations (Scopus)

Langue d'origine	English
Pages (de-à)	452-454
Nombre de pages	3
Journal	Canadian Journal of Ophthalmology
Volume	55
Numéro de publication	5
DOI	https://doi.org/10.1016/j.jcjo.2020.06.001
Statut de publication	Published - oct. 2020

Note bibliographique

Funding Information:
Dr. Varun Chaudhary has investigator-sponsored research grants and participates in clinical trials funded by Novartis, Bayer, and Allergan; Dr. Chaudhary has also served on the advisory board and is consultant for Novartis and Bayer. Dr. Cynthia Qian has served as consultant for Novartis, Bayer, Allergan, and Bausch and Lomb. Dr. Alan Berger serves as consultant and receives honoraria from Novartis, Bayer, Allergan, and Roche. Dr. James Whelan has received honoraria from Alcon, Novartis, and Bayer, and has investigator-sponsored research grants from Novartis. Dr. Amin Kherani participates in clinical trials funded by Novartis, Bayer, Allergan, Alcon, and Bausch and Lomb. Dr. Arif Samad participates in clinical trials funded by, and is consultant with, Novartis and Bayer. Dr. Jason Noble serves on the advisory board of Novartis and Bayer, and is a speaker for Novartis. None of these have any bearing on the current study. The remaining authors have no financial disclosures to declare. This research did not receive any funding or grants from agencies in the public, commercial, or not-for-profit sectors.

Funding Information:
?, Dr. Varun Chaudhary has investigator-sponsored research grants and participates in clinical trials funded by Novartis, Bayer, and Allergan; Dr. Chaudhary has also served on the advisory board and is consultant for Novartis and Bayer. Dr. Cynthia Qian has served as consultant for Novartis, Bayer, Allergan, and Bausch and Lomb. Dr. Alan Berger serves as consultant and receives honoraria from Novartis, Bayer, Allergan, and Roche. Dr. James Whelan has received honoraria from Alcon, Novartis, and Bayer, and has investigator-sponsored research grants from Novartis. Dr. Amin Kherani participates in clinical trials funded by Novartis, Bayer, Allergan, Alcon, and Bausch and Lomb. Dr. Arif Samad participates in clinical trials funded by, and is consultant with, Novartis and Bayer. Dr. Jason Noble serves on the advisory board of Novartis and Bayer, and is a speaker for Novartis. None of these have any bearing on the current study. The remaining authors have no financial disclosures to declare. This research did not receive any funding or grants from agencies in the public, commercial, or not-for-profit sectors.

ASJC Scopus Subject Areas

Ophthalmology

Accès au document

10.1016/j.jcjo.2020.06.001

Autres fichiers et liens

Citer

Chaudhary, V., Rosenberg, D., Barbosa, J., Qian, C., Berger, A., Whelan, J., Kherani, A., Samad, A., & Noble, J. (2020). National survey of Canadian Retina Society members on guidelines for ophthalmic care during the COVID-19 crisis: Canadian Retina Research Network (CR2N) COVID-19 Steering Committee analysis. Canadian Journal of Ophthalmology, 55(5), 452-454. https://doi.org/10.1016/j.jcjo.2020.06.001

National survey of Canadian Retina Society members on guidelines for ophthalmic care during the COVID-19 crisis: Canadian Retina Research Network (CR2N) COVID-19 Steering Committee analysis. / Chaudhary, Varun; Rosenberg, Daniel; Barbosa, Joshua et al.
Dans: Canadian Journal of Ophthalmology, Vol. 55, N° 5, 10.2020, p. 452-454.

Résultat de recherche: Letter › examen par les pairs

Chaudhary, V, Rosenberg, D, Barbosa, J, Qian, C, Berger, A, Whelan, J, Kherani, A, Samad, A & Noble, J 2020, 'National survey of Canadian Retina Society members on guidelines for ophthalmic care during the COVID-19 crisis: Canadian Retina Research Network (CR2N) COVID-19 Steering Committee analysis', Canadian Journal of Ophthalmology, vol. 55, n° 5, pp. 452-454. https://doi.org/10.1016/j.jcjo.2020.06.001

@article{94099bc64fcb4808bf0c361da78f2610,

title = "National survey of Canadian Retina Society members on guidelines for ophthalmic care during the COVID-19 crisis: Canadian Retina Research Network (CR2N) COVID-19 Steering Committee analysis",

author = "Varun Chaudhary and Daniel Rosenberg and Joshua Barbosa and Cynthia Qian and Alan Berger and James Whelan and Amin Kherani and Arif Samad and Jason Noble",

note = "Funding Information: Dr. Varun Chaudhary has investigator-sponsored research grants and participates in clinical trials funded by Novartis, Bayer, and Allergan; Dr. Chaudhary has also served on the advisory board and is consultant for Novartis and Bayer. Dr. Cynthia Qian has served as consultant for Novartis, Bayer, Allergan, and Bausch and Lomb. Dr. Alan Berger serves as consultant and receives honoraria from Novartis, Bayer, Allergan, and Roche. Dr. James Whelan has received honoraria from Alcon, Novartis, and Bayer, and has investigator-sponsored research grants from Novartis. Dr. Amin Kherani participates in clinical trials funded by Novartis, Bayer, Allergan, Alcon, and Bausch and Lomb. Dr. Arif Samad participates in clinical trials funded by, and is consultant with, Novartis and Bayer. Dr. Jason Noble serves on the advisory board of Novartis and Bayer, and is a speaker for Novartis. None of these have any bearing on the current study. The remaining authors have no financial disclosures to declare. This research did not receive any funding or grants from agencies in the public, commercial, or not-for-profit sectors. Funding Information: ?, Dr. Varun Chaudhary has investigator-sponsored research grants and participates in clinical trials funded by Novartis, Bayer, and Allergan; Dr. Chaudhary has also served on the advisory board and is consultant for Novartis and Bayer. Dr. Cynthia Qian has served as consultant for Novartis, Bayer, Allergan, and Bausch and Lomb. Dr. Alan Berger serves as consultant and receives honoraria from Novartis, Bayer, Allergan, and Roche. Dr. James Whelan has received honoraria from Alcon, Novartis, and Bayer, and has investigator-sponsored research grants from Novartis. Dr. Amin Kherani participates in clinical trials funded by Novartis, Bayer, Allergan, Alcon, and Bausch and Lomb. Dr. Arif Samad participates in clinical trials funded by, and is consultant with, Novartis and Bayer. Dr. Jason Noble serves on the advisory board of Novartis and Bayer, and is a speaker for Novartis. None of these have any bearing on the current study. The remaining authors have no financial disclosures to declare. This research did not receive any funding or grants from agencies in the public, commercial, or not-for-profit sectors.",

year = "2020",

month = oct,

doi = "10.1016/j.jcjo.2020.06.001",

language = "English",

volume = "55",

pages = "452--454",

journal = "Canadian Journal of Ophthalmology",

issn = "0008-4182",

publisher = "Canadian Ophthalmological Society",

number = "5",

}

TY - JOUR

T1 - National survey of Canadian Retina Society members on guidelines for ophthalmic care during the COVID-19 crisis

T2 - Canadian Retina Research Network (CR2N) COVID-19 Steering Committee analysis

AU - Chaudhary, Varun

AU - Rosenberg, Daniel

AU - Barbosa, Joshua

AU - Qian, Cynthia

AU - Berger, Alan

AU - Whelan, James

AU - Kherani, Amin

AU - Samad, Arif

AU - Noble, Jason

N1 - Funding Information: Dr. Varun Chaudhary has investigator-sponsored research grants and participates in clinical trials funded by Novartis, Bayer, and Allergan; Dr. Chaudhary has also served on the advisory board and is consultant for Novartis and Bayer. Dr. Cynthia Qian has served as consultant for Novartis, Bayer, Allergan, and Bausch and Lomb. Dr. Alan Berger serves as consultant and receives honoraria from Novartis, Bayer, Allergan, and Roche. Dr. James Whelan has received honoraria from Alcon, Novartis, and Bayer, and has investigator-sponsored research grants from Novartis. Dr. Amin Kherani participates in clinical trials funded by Novartis, Bayer, Allergan, Alcon, and Bausch and Lomb. Dr. Arif Samad participates in clinical trials funded by, and is consultant with, Novartis and Bayer. Dr. Jason Noble serves on the advisory board of Novartis and Bayer, and is a speaker for Novartis. None of these have any bearing on the current study. The remaining authors have no financial disclosures to declare. This research did not receive any funding or grants from agencies in the public, commercial, or not-for-profit sectors. Funding Information: ?, Dr. Varun Chaudhary has investigator-sponsored research grants and participates in clinical trials funded by Novartis, Bayer, and Allergan; Dr. Chaudhary has also served on the advisory board and is consultant for Novartis and Bayer. Dr. Cynthia Qian has served as consultant for Novartis, Bayer, Allergan, and Bausch and Lomb. Dr. Alan Berger serves as consultant and receives honoraria from Novartis, Bayer, Allergan, and Roche. Dr. James Whelan has received honoraria from Alcon, Novartis, and Bayer, and has investigator-sponsored research grants from Novartis. Dr. Amin Kherani participates in clinical trials funded by Novartis, Bayer, Allergan, Alcon, and Bausch and Lomb. Dr. Arif Samad participates in clinical trials funded by, and is consultant with, Novartis and Bayer. Dr. Jason Noble serves on the advisory board of Novartis and Bayer, and is a speaker for Novartis. None of these have any bearing on the current study. The remaining authors have no financial disclosures to declare. This research did not receive any funding or grants from agencies in the public, commercial, or not-for-profit sectors.

PY - 2020/10

Y1 - 2020/10

UR - http://www.scopus.com/inward/record.url?scp=85089098649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089098649&partnerID=8YFLogxK

U2 - 10.1016/j.jcjo.2020.06.001

DO - 10.1016/j.jcjo.2020.06.001

M3 - Letter

C2 - 32652047

AN - SCOPUS:85089098649

SN - 0008-4182

VL - 55

SP - 452

EP - 454

JO - Canadian Journal of Ophthalmology

JF - Canadian Journal of Ophthalmology

IS - 5

ER -